Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
Clinical trial NCT06137755 · RECRUITING
Trial details
- NCT number
- NCT06137755
- Sponsor
- Aribio Lab Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2025-03-21
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.